Candel Therapeutics Correlations

CADL Stock

USD 7.75 3.14 68.11%

The current 90-days correlation between Candel Therapeutics and Aerovate Therapeutics is 0.05 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Candel Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Candel Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Candel Therapeutics Correlation With Market

Significant diversification

The correlation between Candel Therapeutics and DJI is 0.03 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Candel Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Candel Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

For more information on how to buy Candel Stock please use our How to buy in Candel Stock guide.

Moving together with Candel Stock

0.67	VALN	Valneva SE ADR	Pair Corr
0.69	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.78	LLY	Eli Lilly	Pair Corr
0.9	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.79	PFE	Pfizer Inc Fiscal Year End 4th of February 2025	Pair Corr
0.75	SXTPW	60 Degrees Pharmaceu	Pair Corr
0.83	MRVI	Maravai Lifesciences	Pair Corr
0.87	REGN	Regeneron Pharmaceuticals	Pair Corr
0.86	AKAN	Akanda Corp	Pair Corr
0.69	AMGN	Amgen Inc	Pair Corr
0.75	ANRO	Alto Neuroscience,	Pair Corr
0.69	ARDX	Ardelyx	Pair Corr

Moving against Candel Stock

0.82	BMY	Bristol Myers Squibb	Pair Corr
0.76	GILD	Gilead Sciences	Pair Corr
0.62	ESPR	Esperion Therapeutics	Pair Corr
0.35	DYAI	Dyadic International	Pair Corr
0.71	MNMD	Mind Medicine	Pair Corr
0.51	ABCL	Abcellera Biologics	Pair Corr
0.5	MOLN	Molecular Partners	Pair Corr
0.43	ALVO	Alvotech	Pair Corr
0.8	TARS	Tarsus Pharmaceuticals	Pair Corr

Related Correlations Analysis

	AVTE	ADAG	ACRV	RZLT	ANTX	MOLN	MLYS	PHVS	PEPG	PMVP
AVTE		-0.07	-0.17	0.37	0.55	0.47	0.34	0.39	-0.87	0.73	AVTE
ADAG	-0.07		0.8	0.54	-0.29	0.55	0.25	0.64	0.2	0.33	ADAG
ACRV	-0.17	0.8		0.47	-0.33	0.38	0.21	0.5	0.27	0.25	ACRV
RZLT	0.37	0.54	0.47		-0.09	0.68	0.17	0.47	-0.36	0.65	RZLT
ANTX	0.55	-0.29	-0.33	-0.09		0.25	0.02	0.0	-0.56	0.29	ANTX
MOLN	0.47	0.55	0.38	0.68	0.25		0.35	0.59	-0.43	0.76	MOLN
MLYS	0.34	0.25	0.21	0.17	0.02	0.35		0.33	0.01	0.54	MLYS
PHVS	0.39	0.64	0.5	0.47	0.0	0.59	0.33		-0.27	0.55	PHVS
PEPG	-0.87	0.2	0.27	-0.36	-0.56	-0.43	0.01	-0.27		-0.56	PEPG
PMVP	0.73	0.33	0.25	0.65	0.29	0.76	0.54	0.55	-0.56		PMVP
	AVTE	ADAG	ACRV	RZLT	ANTX	MOLN	MLYS	PHVS	PEPG	PMVP

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ACRV	+ 0.8	ADAG
PMVP	+ 0.76	MOLN
PMVP	+ 0.73	AVTE
MOLN	+ 0.68	RZLT
PMVP	+ 0.65	RZLT
PHVS	+ 0.64	ADAG

High negative correlations

PEPG	- 0.87	AVTE
PMVP	- 0.56	PEPG
PEPG	- 0.56	ANTX
PEPG	- 0.43	MOLN
PEPG	- 0.36	RZLT
ANTX	- 0.33	ACRV

Risk-Adjusted Indicators

There is a big difference between Candel Stock performing well and Candel Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Candel Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
AVTE	2.38	0.45	0.17	0.73	1.99	(3.25)	5.58	(3.86)	19.11
ADAG	4.74	(0.33)	0.00	4.21	0.00	0.00	8.13	(14.29)	37.93
ACRV	2.75	(0.29)	0.00	(0.11)	0.00	0.00	6.90	(7.65)	22.84
RZLT	2.51	(0.07)	0.00	(0.94)	0.00	0.00	5.54	(5.36)	16.12
ANTX	2.42	0.60	0.21	0.76	1.83	(4.04)	6.34	(4.19)	28.89
MOLN	4.31	0.37	0.02	(0.15)	4.58	(5.90)	9.38	(7.22)	52.92
MLYS	2.77	(0.05)	0.02	0.09	3.30	(2.96)	7.51	(5.67)	20.98
PHVS	2.88	(0.30)	0.00	(0.04)	0.00	0.00	6.79	(7.49)	23.21
PEPG	3.64	(0.74)	0.00	(2.32)	0.00	0.00	6.69	(9.02)	26.81
PMVP	1.68	0.01	0.00	0.13	2.10	(2.17)	4.35	(4.57)	13.98

Candel Therapeutics Corporate Management

Francesca MD	Chief Officer	Profile
LLM JD	Chief Officer	Profile
Nathan Caffo	Chief Officer	Profile
MS MD	Chief Officer	Profile
FMEDSCI MD	CEO Pres	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC